Labelling of bleomycin with Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines

International Journal of Radiation Biology

Volumn 73, Issue 5, 1998, Pages 565-570

  Jaaskela Saari H A ^a   Kairemo, K J A ^a   Ramsay, H A ^a   Grenman R ^b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; INDIUM 111;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CYTOPATHOGENIC EFFECT; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DRUG SCREENING ASSAYS, ANTITUMOR; HEAD AND NECK NEOPLASMS; HUMANS; INDIUM; INDIUM RADIOISOTOPES; ISOTOPE LABELING; TUMOR CELLS, CULTURED;

EID: 0031864307     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530098142121     Document Type: Article

References (34)

1. AISHNFR, J., HIPONIA, D., CONLEY, B., JACOBS, M., GRAY, W. and BELANI, C. P., 1995, Combined modalities in the treatment of head and neck cancers. Seminars in Oncology, 22 (3 Suppl. 6), 28-34.
2. BARLOGIE, B., DREWINKO, B., SSCHUMANN, J. and FREIREICH, E. J., 1976, Pulse cytophotometric analysis of cell cycle perturbation with bleomycin in vitro. Cancer Research, 36, 1182-1187.
3. BARRANCO, S. C. and HUMPHREY, R. M., 1971, The effects of bleomycin on survival and cell progression in Chinese hamster cells in vitro. Cancer Research, 31, 1218-1223.
4. BARRANCO, S. C., NOVAK, J. K. and HUMPHREY, R. M., 1973, Response of mammalian cells following treatment with bleomycin and 1,3-Bis(2-chloroethyl)-1-nitrosurea during plateau phase. Cancer Research, 33, 691-694.
5. CLEYMAN, G. L., WEBER, R. S., GUILLAMONDEGUI, O., BYERS, R. M., WOLF, P. F., FRANKENTIIALER, R. A., MORRISON, W. H., GARDEN, A. S., HONG, W. K. and GOEPFERT, H., 1995, Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers. Archives of Otolaryngology - Head and Neck Surgery, 121, 219-223.
6. CUMMINGS, C. W., LARSON, S. M., DOBIE, R. A., WEYMULLER, E. A., JR, RUDD, T. G. and MERELLO, A., 1981, Assessment of cobalt 57 tagged bleomycin as a clinical aid in staging of head and neck carcinoma. Laryngoscope, 91, 529-537.
7. EISENBERGER, M. and JACOBS, M., 1992, Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of the head and neck. Seminars in Oncology, 19 (4Suppl. 11), 41-46.
8. FU, K. K., PHILLIPS, T. L., SILVERBERG, I. J., JACOBS, C., GOFFINET, D. R., CHUN, C., FRIEDMAN, M. A., KOHLER, M., MCWHIRTER, K. and CARTER, S. K., 1987, Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer. Journal of Clinical Oncology. 5, 1410-1415.
9. GRENMAN, R., BURK, D. and VIROLAINEN, E., 1989. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. International Journal of Cancer, 44, 131-136.
10. GRENMAN, R., BURK, D., VIROLAINEN, E. and Wagner, J. G., 1988, Radiosensitivity of head and neck cancer cells in vitro. Archives of Otolarynology - Head and Neck Surgery, 114, 427-431.
11. GRENMAN, R., CAREY, T. E., MCCLATCHEY, K. D., et al. 1991, In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer, 67, 2741-2747.
12. HILTUNEN, J. V., KAIREMO, K. J. A. and NIKULA, T. K., 1990, Pharmacokinetic properties of low pH In-111-bleomycin complex. In Advances in Radiopharmacology. Proceedings of the Sixth International Symposium on Radiopharmacology, International Association of Radiopharmacology 1990, Sydney, Australia, edited by D. J. Maddalena, G. M. Snowdon and G. R. Boniface (Australia: Wollongong University Press), pp. 136-139.
13. 111In]BLMC. Cancer Investigation, 7, 543-550.
14. 111In-bleomycin complex for tumor imaging: preparation, stability, and distribution in glioma-bearing mice. Journal of Surgical Oncology, 25, 168-175.
15. 111In-bleomycin complex for combined radiotherapy and chemotherapy. Journal of Surgical Oncology, 29, 91-98.
16. 111Inbleomycin complex in small cell lung cancer cells by autoradiography. Journal of Surgical Oncology, 49, 93-97.
17. 111In-bleomycin complex. Journal of Surgical Oncology, 51, 236-242.
18. Hou, D.-Y., ORDONEZ, J. V., CROSS, R. J., Ross, D. D. and MARUYAMA, Y., 1989b, Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complex. Journal of Surgical Oncology, 40, 73-78.
19. HOWELL, R. W., NARRA, V. R., SASTRY, K. S. R. and RAO, D. V., 1993, On the equivalent dose for Auger electron emitters. Radiation Research, 134, 71-78.
20. JAASKELA-SAARI, H. A., KAIREMO, K. J. A., JEKUNEN, A. P., PEKKOLA-HEINO, K., KULMALA, J., RAMSAY, H. A. and GRENMAN, R., 1996, Cytotoxicity of bleomycin and external radiation in squamous cell cancer cell lines of head and neck. Cancer Detection and Prevention, 20, 279-284.
21. KAIREMO, K. J. A., RAMSAY, H. A., PAAVONKN, T. and BONDESTAM, S., 1996a, Imaging and staging of head and neck cancer using a low pH In-111-bleomycin complex. European Journal of Cancer, 32, 311-321.
22. KAIREMO, K. J. A., RAMSAY, H. A., TAGESSON, M., JEKUNEN, A. P., PAAVONEN, T. K., JAASKELA-SAARI, H. A., LIEWENDAHL, K., LJUNGGREN, K., SAVOLAINEN, S. and STRAND, S.-E., 1996b, Indium-111-bleomycin complex for radiochemotherapy of head and neck cancer - dosimetric and biokinetic aspects. European Journal of Nuclear Medicine, 23, 631-638.
23. KUO, M. T. and HAIDLE, C. W., 1973, Characterization of chain breakage in DNA induced by bleomycin. Biochimica et Biophysica Acta, 335, 109-114.
24. ORFORD, J., BARKER, A., THONELL, S., KING, P. and MURPHY, J., 1995, Bleomycin therapy for cystic hygroma. Journal of Pediatric Surgery, 30, 1282-1287.
25. PEKKOLA-HEINO, K., KULMALA, J. and GRENMAN, R., 1992, Carboplatin-radiation interaction in squamous cell carcinoma cell lines. Archives of Otolaryngology - Head and Neck Surgery, 118, 1312-1315.
26. SHANTA, V. and KRISHNAMURTHI, S., 1980, Combination bleomycin and radiation in oral cancer. Clinical Radiology, 31, 617-621.
27. SMID, L., LESNICAR, H., ZAKOTNIK, B., SOBA, K., BUDIHNA, M., FURLAN, L., ZARGI, M. and RUDOLF, Z., 1995, Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck canter - preliminary report. International Journal of Radiation Oncology, Biology, Physics, 32, 769-775.
28. SUNG, M. W., CHANG, S. O., CHOI, J. H. and KIM, J. Y., 1995, Blcomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. American Journal of Otolaryngology, 16, 236-241.
29. THAKUR, M. L., MENNICK, M. V. and GUANASEKERA, S. W., 1973, Some pharmacological aspects of new radiopharmaceutical 111-In-bleomycin. In Radiopharmaceuticals and Labelled Compounds, Vol. II (Vienna: IAEA), pp. 183-193.
30. THILLY, W. G., DELUCA, J. G., FURTH, E. E., et al., 1980, Genelocus mutation assays in diploid human lymphoblast lines. In Chemical Mutagens, Vol. 1, edited by F. J. De Serpes and A. Hollaender (New York: Plenum Publishing), pp. 331-364.
31. UMEZAWA, H., MAEDA, K., TAKEUGHI, T. and OKAMI, Y., 1966, New antibiotics, bleomycin A and B. Journal of Antibiotics (A), 19, 200-209.
32. URADE, M., OGURA, T., MIWA, T. and MATSUYA, T., 1992, Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity. Cancer, 69, 2589-2597.
33. 2. Canter Research, 52, 2569-2574.
34. VETERANS AFFAIRS LARYNGEAL CANCER STUDY GROUP, 1991, Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. New England Journal of Medicine, 324, 1685-1690.